We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleGlyco-engineered anti-EGFR mAb elicits ADCC by NK cells from colorectal cancer patients irrespective of chemotherapy.AuthorsOppenheim DE; Spreafico R; Etuk A; Malone D; Amofah E; Peña-Murillo C; Murray T; McLaughlin L; Choi BS; Allan S; Belousov A; Passioukov A; Gerdes C; Umaña P; Farzaneh F; Ross PPublicationBritish journal of cancer, 2014, Vol 110, Issue 5, p1221ISSN1532-1827Publication typearticleDOI10.1038/bjc.2014.35